Article info

Original research
Antidopaminergic treatment is associated with reduced chorea and irritability but impaired cognition in Huntington’s disease (Enroll-HD)

Authors

  1. Correspondence to Kate L Harris, Clinical Neurosciences, The University of Cambridge, Cambridge CB2 1TN, UK; kh600{at}cam.ac.uk
View Full Text

Citation

Harris KL, Kuan W, Mason SL, et al
Antidopaminergic treatment is associated with reduced chorea and irritability but impaired cognition in Huntington’s disease (Enroll-HD)

Publication history

  • Received September 10, 2019
  • Revised February 26, 2020
  • Accepted March 13, 2020
  • First published March 30, 2020.
Online issue publication 
May 15, 2020

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Related Data

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.